img

Global Lacosamide Injection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lacosamide Injection Market Insights, Forecast to 2034

Global Lacosamide Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Lacosamide Injection industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Lacosamide Injection key manufacturers include Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc., Jiangsu Haian Pharmaceutical Co., Ltd., Jiangxi Kerui Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Camber Pharmaceuticals and Fresenius Kabi, etc. Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Lacosamide Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Lacosamide Injection market and estimated to attract more attentions from industry insiders and investors.
Lacosamide Injection can be divided into Generic Drug and Original Drug, etc. Generic Drug is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Lacosamide Injection is widely used in various fields, such as Hospital, Retail Drug Store, Online Sales and Others, etc. Hospital provides greatest supports to the Lacosamide Injection industry development. In 2022, global % sales of Lacosamide Injection went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Lacosamide Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Lacosamide Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Chengdu Lier Pharmaceutical Co., Ltd.
Hefei Yifan Biopharmaceuticals Inc.
Jiangsu Haian Pharmaceutical Co., Ltd.
Jiangxi Kerui Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
UCB Pharma Limited
Camber Pharmaceuticals
Fresenius Kabi
Segment by Type
Generic Drug
Original Drug

Segment by Application


Hospital
Retail Drug Store
Online Sales
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Lacosamide Injection plant distribution, commercial date of Lacosamide Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Lacosamide Injection introduction, etc. Lacosamide Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Lacosamide Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Lacosamide Injection Product Introduction
1.2 Market by Type
1.2.1 Global Lacosamide Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Market by Application
1.3.1 Global Lacosamide Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Drug Store
1.3.4 Online Sales
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lacosamide Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Lacosamide Injection Revenue by Region
2.2.1 Global Lacosamide Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lacosamide Injection Revenue by Region (2018-2024)
2.2.3 Global Lacosamide Injection Revenue by Region (2024-2029)
2.2.4 Global Lacosamide Injection Revenue Market Share by Region (2018-2029)
2.3 Global Lacosamide Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Lacosamide Injection Sales by Region
2.4.1 Global Lacosamide Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lacosamide Injection Sales by Region (2018-2024)
2.4.3 Global Lacosamide Injection Sales by Region (2024-2029)
2.4.4 Global Lacosamide Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lacosamide Injection Sales by Manufacturers
3.1.1 Global Lacosamide Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Lacosamide Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lacosamide Injection in 2022
3.2 Global Lacosamide Injection Revenue by Manufacturers
3.2.1 Global Lacosamide Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Lacosamide Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Lacosamide Injection Revenue in 2022
3.3 Global Key Players of Lacosamide Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Lacosamide Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lacosamide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lacosamide Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lacosamide Injection, Product Offered and Application
3.8 Global Key Manufacturers of Lacosamide Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lacosamide Injection Sales by Type
4.1.1 Global Lacosamide Injection Historical Sales by Type (2018-2024)
4.1.2 Global Lacosamide Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Lacosamide Injection Sales Market Share by Type (2018-2029)
4.2 Global Lacosamide Injection Revenue by Type
4.2.1 Global Lacosamide Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Lacosamide Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lacosamide Injection Revenue Market Share by Type (2018-2029)
4.3 Global Lacosamide Injection Price by Type
4.3.1 Global Lacosamide Injection Price by Type (2018-2024)
4.3.2 Global Lacosamide Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Lacosamide Injection Sales by Application
5.1.1 Global Lacosamide Injection Historical Sales by Application (2018-2024)
5.1.2 Global Lacosamide Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Lacosamide Injection Sales Market Share by Application (2018-2029)
5.2 Global Lacosamide Injection Revenue by Application
5.2.1 Global Lacosamide Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Lacosamide Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lacosamide Injection Revenue Market Share by Application (2018-2029)
5.3 Global Lacosamide Injection Price by Application
5.3.1 Global Lacosamide Injection Price by Application (2018-2024)
5.3.2 Global Lacosamide Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Lacosamide Injection Market Size by Type
6.1.1 US & Canada Lacosamide Injection Sales by Type (2018-2029)
6.1.2 US & Canada Lacosamide Injection Revenue by Type (2018-2029)
6.2 US & Canada Lacosamide Injection Market Size by Application
6.2.1 US & Canada Lacosamide Injection Sales by Application (2018-2029)
6.2.2 US & Canada Lacosamide Injection Revenue by Application (2018-2029)
6.3 US & Canada Lacosamide Injection Market Size by Country
6.3.1 US & Canada Lacosamide Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lacosamide Injection Sales by Country (2018-2029)
6.3.3 US & Canada Lacosamide Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lacosamide Injection Market Size by Type
7.1.1 Europe Lacosamide Injection Sales by Type (2018-2029)
7.1.2 Europe Lacosamide Injection Revenue by Type (2018-2029)
7.2 Europe Lacosamide Injection Market Size by Application
7.2.1 Europe Lacosamide Injection Sales by Application (2018-2029)
7.2.2 Europe Lacosamide Injection Revenue by Application (2018-2029)
7.3 Europe Lacosamide Injection Market Size by Country
7.3.1 Europe Lacosamide Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lacosamide Injection Sales by Country (2018-2029)
7.3.3 Europe Lacosamide Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lacosamide Injection Market Size
8.1.1 China Lacosamide Injection Sales (2018-2029)
8.1.2 China Lacosamide Injection Revenue (2018-2029)
8.2 China Lacosamide Injection Market Size by Application
8.2.1 China Lacosamide Injection Sales by Application (2018-2029)
8.2.2 China Lacosamide Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Lacosamide Injection Market Size by Type
9.1.1 Asia Lacosamide Injection Sales by Type (2018-2029)
9.1.2 Asia Lacosamide Injection Revenue by Type (2018-2029)
9.2 Asia Lacosamide Injection Market Size by Application
9.2.1 Asia Lacosamide Injection Sales by Application (2018-2029)
9.2.2 Asia Lacosamide Injection Revenue by Application (2018-2029)
9.3 Asia Lacosamide Injection Sales by Region
9.3.1 Asia Lacosamide Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lacosamide Injection Revenue by Region (2018-2029)
9.3.3 Asia Lacosamide Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lacosamide Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Lacosamide Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lacosamide Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lacosamide Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Lacosamide Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lacosamide Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lacosamide Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Lacosamide Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lacosamide Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lacosamide Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd.
11.1.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Information
11.1.2 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Overview
11.1.3 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Recent Developments
11.2 Chengdu Lier Pharmaceutical Co., Ltd.
11.2.1 Chengdu Lier Pharmaceutical Co., Ltd. Company Information
11.2.2 Chengdu Lier Pharmaceutical Co., Ltd. Overview
11.2.3 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chengdu Lier Pharmaceutical Co., Ltd. Recent Developments
11.3 Hefei Yifan Biopharmaceuticals Inc.
11.3.1 Hefei Yifan Biopharmaceuticals Inc. Company Information
11.3.2 Hefei Yifan Biopharmaceuticals Inc. Overview
11.3.3 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hefei Yifan Biopharmaceuticals Inc. Recent Developments
11.4 Jiangsu Haian Pharmaceutical Co., Ltd.
11.4.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
11.4.2 Jiangsu Haian Pharmaceutical Co., Ltd. Overview
11.4.3 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Haian Pharmaceutical Co., Ltd. Recent Developments
11.5 Jiangxi Kerui Pharmaceutical Co., Ltd.
11.5.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
11.5.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Overview
11.5.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments
11.6 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
11.6.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
11.6.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Overview
11.6.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments
11.7 UCB Pharma Limited
11.7.1 UCB Pharma Limited Company Information
11.7.2 UCB Pharma Limited Overview
11.7.3 UCB Pharma Limited Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 UCB Pharma Limited Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 UCB Pharma Limited Recent Developments
11.8 Camber Pharmaceuticals
11.8.1 Camber Pharmaceuticals Company Information
11.8.2 Camber Pharmaceuticals Overview
11.8.3 Camber Pharmaceuticals Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Camber Pharmaceuticals Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Camber Pharmaceuticals Recent Developments
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Company Information
11.9.2 Fresenius Kabi Overview
11.9.3 Fresenius Kabi Lacosamide Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Fresenius Kabi Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Fresenius Kabi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lacosamide Injection Industry Chain Analysis
12.2 Lacosamide Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lacosamide Injection Production Mode & Process
12.4 Lacosamide Injection Sales and Marketing
12.4.1 Lacosamide Injection Sales Channels
12.4.2 Lacosamide Injection Distributors
12.5 Lacosamide Injection Customers
13 Market Dynamics
13.1 Lacosamide Injection Industry Trends
13.2 Lacosamide Injection Market Drivers
13.3 Lacosamide Injection Market Challenges
13.4 Lacosamide Injection Market Restraints
14 Key Findings in The Global Lacosamide Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Lacosamide Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Generic Drug
Table 3. Major Manufacturers of Original Drug
Table 4. Global Lacosamide Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Lacosamide Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Lacosamide Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Lacosamide Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Lacosamide Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Lacosamide Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Lacosamide Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Lacosamide Injection Sales by Region (2018-2024) & (K Boxes)
Table 12. Global Lacosamide Injection Sales by Region (2024-2029) & (K Boxes)
Table 13. Global Lacosamide Injection Sales Market Share by Region (2018-2024)
Table 14. Global Lacosamide Injection Sales Market Share by Region (2024-2029)
Table 15. Global Lacosamide Injection Sales by Manufacturers (2018-2024) & (K Boxes)
Table 16. Global Lacosamide Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Lacosamide Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Lacosamide Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Lacosamide Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Lacosamide Injection Price by Manufacturers 2018-2024 (US$/Box)
Table 21. Global Lacosamide Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Lacosamide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Injection as of 2022)
Table 23. Global Key Manufacturers of Lacosamide Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Lacosamide Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Lacosamide Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Lacosamide Injection Sales by Type (2018-2024) & (K Boxes)
Table 28. Global Lacosamide Injection Sales by Type (2024-2029) & (K Boxes)
Table 29. Global Lacosamide Injection Sales Share by Type (2018-2024)
Table 30. Global Lacosamide Injection Sales Share by Type (2024-2029)
Table 31. Global Lacosamide Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Lacosamide Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Lacosamide Injection Revenue Share by Type (2018-2024)
Table 34. Global Lacosamide Injection Revenue Share by Type (2024-2029)
Table 35. Lacosamide Injection Price by Type (2018-2024) & (US$/Box)
Table 36. Global Lacosamide Injection Price Forecast by Type (2024-2029) & (US$/Box)
Table 37. Global Lacosamide Injection Sales by Application (2018-2024) & (K Boxes)
Table 38. Global Lacosamide Injection Sales by Application (2024-2029) & (K Boxes)
Table 39. Global Lacosamide Injection Sales Share by Application (2018-2024)
Table 40. Global Lacosamide Injection Sales Share by Application (2024-2029)
Table 41. Global Lacosamide Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Lacosamide Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Lacosamide Injection Revenue Share by Application (2018-2024)
Table 44. Global Lacosamide Injection Revenue Share by Application (2024-2029)
Table 45. Lacosamide Injection Price by Application (2018-2024) & (US$/Box)
Table 46. Global Lacosamide Injection Price Forecast by Application (2024-2029) & (US$/Box)
Table 47. US & Canada Lacosamide Injection Sales by Type (2018-2024) & (K Boxes)
Table 48. US & Canada Lacosamide Injection Sales by Type (2024-2029) & (K Boxes)
Table 49. US & Canada Lacosamide Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Lacosamide Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Lacosamide Injection Sales by Application (2018-2024) & (K Boxes)
Table 52. US & Canada Lacosamide Injection Sales by Application (2024-2029) & (K Boxes)
Table 53. US & Canada Lacosamide Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Lacosamide Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Lacosamide Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Lacosamide Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Lacosamide Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Lacosamide Injection Sales by Country (2018-2024) & (K Boxes)
Table 59. US & Canada Lacosamide Injection Sales by Country (2024-2029) & (K Boxes)
Table 60. Europe Lacosamide Injection Sales by Type (2018-2024) & (K Boxes)
Table 61. Europe Lacosamide Injection Sales by Type (2024-2029) & (K Boxes)
Table 62. Europe Lacosamide Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Lacosamide Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Lacosamide Injection Sales by Application (2018-2024) & (K Boxes)
Table 65. Europe Lacosamide Injection Sales by Application (2024-2029) & (K Boxes)
Table 66. Europe Lacosamide Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Lacosamide Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Lacosamide Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Lacosamide Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Lacosamide Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Lacosamide Injection Sales by Country (2018-2024) & (K Boxes)
Table 72. Europe Lacosamide Injection Sales by Country (2024-2029) & (K Boxes)
Table 73. China Lacosamide Injection Sales by Type (2018-2024) & (K Boxes)
Table 74. China Lacosamide Injection Sales by Type (2024-2029) & (K Boxes)
Table 75. China Lacosamide Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Lacosamide Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Lacosamide Injection Sales by Application (2018-2024) & (K Boxes)
Table 78. China Lacosamide Injection Sales by Application (2024-2029) & (K Boxes)
Table 79. China Lacosamide Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Lacosamide Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Lacosamide Injection Sales by Type (2018-2024) & (K Boxes)
Table 82. Asia Lacosamide Injection Sales by Type (2024-2029) & (K Boxes)
Table 83. Asia Lacosamide Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Lacosamide Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Lacosamide Injection Sales by Application (2018-2024) & (K Boxes)
Table 86. Asia Lacosamide Injection Sales by Application (2024-2029) & (K Boxes)
Table 87. Asia Lacosamide Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Lacosamide Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Lacosamide Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Lacosamide Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Lacosamide Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Lacosamide Injection Sales by Region (2018-2024) & (K Boxes)
Table 93. Asia Lacosamide Injection Sales by Region (2024-2029) & (K Boxes)
Table 94. Middle East, Africa and Latin America Lacosamide Injection Sales by Type (2018-2024) & (K Boxes)
Table 95. Middle East, Africa and Latin America Lacosamide Injection Sales by Type (2024-2029) & (K Boxes)
Table 96. Middle East, Africa and Latin America Lacosamide Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Lacosamide Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Lacosamide Injection Sales by Application (2018-2024) & (K Boxes)
Table 99. Middle East, Africa and Latin America Lacosamide Injection Sales by Application (2024-2029) & (K Boxes)
Table 100. Middle East, Africa and Latin America Lacosamide Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lacosamide Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Lacosamide Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Lacosamide Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Lacosamide Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lacosamide Injection Sales by Country (2018-2024) & (K Boxes)
Table 106. Middle East, Africa and Latin America Lacosamide Injection Sales by Country (2024-2029) & (K Boxes)
Table 107. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Information
Table 108. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Description and Major Businesses
Table 109. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 110. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Recent Developments
Table 112. Chengdu Lier Pharmaceutical Co., Ltd. Company Information
Table 113. Chengdu Lier Pharmaceutical Co., Ltd. Description and Major Businesses
Table 114. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 115. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Chengdu Lier Pharmaceutical Co., Ltd. Recent Developments
Table 117. Hefei Yifan Biopharmaceuticals Inc. Company Information
Table 118. Hefei Yifan Biopharmaceuticals Inc. Description and Major Businesses
Table 119. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 120. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Hefei Yifan Biopharmaceuticals Inc. Recent Developments
Table 122. Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
Table 123. Jiangsu Haian Pharmaceutical Co., Ltd. Description and Major Businesses
Table 124. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 125. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Jiangsu Haian Pharmaceutical Co., Ltd. Recent Developments
Table 127. Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
Table 128. Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Major Businesses
Table 129. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 130. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments
Table 132. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
Table 133. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Major Businesses
Table 134. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 135. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments
Table 137. UCB Pharma Limited Company Information
Table 138. UCB Pharma Limited Description and Major Businesses
Table 139. UCB Pharma Limited Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 140. UCB Pharma Limited Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. UCB Pharma Limited Recent Developments
Table 142. Camber Pharmaceuticals Company Information
Table 143. Camber Pharmaceuticals Description and Major Businesses
Table 144. Camber Pharmaceuticals Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 145. Camber Pharmaceuticals Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Camber Pharmaceuticals Recent Developments
Table 147. Fresenius Kabi Company Information
Table 148. Fresenius Kabi Description and Major Businesses
Table 149. Fresenius Kabi Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 150. Fresenius Kabi Lacosamide Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Fresenius Kabi Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Lacosamide Injection Distributors List
Table 155. Lacosamide Injection Customers List
Table 156. Lacosamide Injection Market Trends
Table 157. Lacosamide Injection Market Drivers
Table 158. Lacosamide Injection Market Challenges
Table 159. Lacosamide Injection Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Lacosamide Injection Product Picture
Figure 2. Global Lacosamide Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lacosamide Injection Market Share by Type in 2022 & 2029
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Lacosamide Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Lacosamide Injection Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Retail Drug Store
Figure 10. Online Sales
Figure 11. Others
Figure 12. Lacosamide Injection Report Years Considered
Figure 13. Global Lacosamide Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Lacosamide Injection Revenue 2018-2029 (US$ Million)
Figure 15. Global Lacosamide Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Lacosamide Injection Revenue Market Share by Region (2018-2029)
Figure 17. Global Lacosamide Injection Sales 2018-2029 ((K Boxes)
Figure 18. Global Lacosamide Injection Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Lacosamide Injection Sales YoY (2018-2029) & (K Boxes)
Figure 20. US & Canada Lacosamide Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Lacosamide Injection Sales YoY (2018-2029) & (K Boxes)
Figure 22. Europe Lacosamide Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Lacosamide Injection Sales YoY (2018-2029) & (K Boxes)
Figure 24. China Lacosamide Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Lacosamide Injection Sales YoY (2018-2029) & (K Boxes)
Figure 26. Asia (excluding China) Lacosamide Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Lacosamide Injection Sales YoY (2018-2029) & (K Boxes)
Figure 28. Middle East, Africa and Latin America Lacosamide Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Lacosamide Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Lacosamide Injection in the World: Market Share by Lacosamide Injection Revenue in 2022
Figure 31. Global Lacosamide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Lacosamide Injection Sales Market Share by Type (2018-2029)
Figure 33. Global Lacosamide Injection Revenue Market Share by Type (2018-2029)
Figure 34. Global Lacosamide Injection Sales Market Share by Application (2018-2029)
Figure 35. Global Lacosamide Injection Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Lacosamide Injection Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Lacosamide Injection Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Lacosamide Injection Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Lacosamide Injection Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Lacosamide Injection Revenue Share by Country (2018-2029)
Figure 41. US & Canada Lacosamide Injection Sales Share by Country (2018-2029)
Figure 42. U.S. Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Lacosamide Injection Sales Market Share by Type (2018-2029)
Figure 45. Europe Lacosamide Injection Revenue Market Share by Type (2018-2029)
Figure 46. Europe Lacosamide Injection Sales Market Share by Application (2018-2029)
Figure 47. Europe Lacosamide Injection Revenue Market Share by Application (2018-2029)
Figure 48. Europe Lacosamide Injection Revenue Share by Country (2018-2029)
Figure 49. Europe Lacosamide Injection Sales Share by Country (2018-2029)
Figure 50. Germany Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 51. France Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 55. China Lacosamide Injection Sales Market Share by Type (2018-2029)
Figure 56. China Lacosamide Injection Revenue Market Share by Type (2018-2029)
Figure 57. China Lacosamide Injection Sales Market Share by Application (2018-2029)
Figure 58. China Lacosamide Injection Revenue Market Share by Application (2018-2029)
Figure 59. Asia Lacosamide Injection Sales Market Share by Type (2018-2029)
Figure 60. Asia Lacosamide Injection Revenue Market Share by Type (2018-2029)
Figure 61. Asia Lacosamide Injection Sales Market Share by Application (2018-2029)
Figure 62. Asia Lacosamide Injection Revenue Market Share by Application (2018-2029)
Figure 63. Asia Lacosamide Injection Revenue Share by Region (2018-2029)
Figure 64. Asia Lacosamide Injection Sales Share by Region (2018-2029)
Figure 65. Japan Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 69. India Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Lacosamide Injection Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Lacosamide Injection Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Lacosamide Injection Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Lacosamide Injection Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Lacosamide Injection Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Lacosamide Injection Sales Share by Country (2018-2029)
Figure 76. Brazil Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Lacosamide Injection Revenue (2018-2029) & (US$ Million)
Figure 81. Lacosamide Injection Value Chain
Figure 82. Lacosamide Injection Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries